Bogart Wealth LLC Has $14.40 Million Holdings in CME Group Inc. (NASDAQ:CME)

Bogart Wealth LLC raised its position in CME Group Inc. (NASDAQ:CME) by 10.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 65,256 shares of the financial services provider’s stock after purchasing an additional 6,330 shares during the quarter. CME Group accounts for approximately 0.7% of Bogart Wealth LLC’s holdings, making the stock its 29th largest holding. Bogart Wealth LLC’s holdings in CME Group were worth $14,399,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Oak Harvest Investment Services boosted its position in CME Group by 66.5% during the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after acquiring an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after acquiring an additional 8,443 shares during the last quarter. Duality Advisers LP acquired a new position in CME Group during the first quarter valued at approximately $1,455,000. SG Americas Securities LLC raised its stake in shares of CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after purchasing an additional 42,996 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after buying an additional 38,540 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on CME shares. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday. Oppenheimer raised their price objective on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday. Morgan Stanley boosted their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Finally, TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $222.07.

CME Group Stock Performance

NASDAQ CME traded up $2.51 during trading on Thursday, reaching $229.65. The company’s stock had a trading volume of 420,210 shares, compared to its average volume of 1,930,872. The firm has a 50 day moving average price of $218.08 and a 200 day moving average price of $208.66. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.30. The firm has a market capitalization of $82.69 billion, a price-to-earnings ratio of 26.06, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the company posted $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.